Autolus Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Autolus Therapeutics generated cash of -$145,587,000, which is less than the previous year. Cash used in financing activities reached the amount of -$883,000 last year. Net change in cash is therefore -$142,426,000.
Cash Flow
| 2015 | -3.32M | -754.14K | 12.22M |
|---|---|---|---|
| 2016 | -9.84M | -1.85M | 32.22M |
| 2017 | -16.36M | -2.87M | 127.68M |
| 2018 | -25.84M | -7.64M | 117.48M |
| 2019 | -101.48M | -18.66M | 108.86M |
| 2020 | -117.75M | -14.68M | 74.41M |
| 2021 | -117.86M | -8.85M | 284.06M |
| 2022 | -112.30M | -10.84M | 223.61M |
| 2023 | -145.58M | -10.98M | -883K |
AUTL Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 382.76M | 310.67M | 154.08M | 211.43M | 217.55M | 102.31M | 28.05M | 10.20M | 0 |
Operating activities | |||||||||
Net income | -208.38M | -148.83M | -142.09M | -142.09M | -123.84M | -31.11M | -19.72M | -12.55M | -7.46M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 6.56M | 7.42M | 8.45M | 5.65M | 4.61M | 1.10M | 1.00M | 478K | 3.63M |
Stock-based compensation expense | 11.20M | 12.01M | 9.93M | 20.10M | 30.21M | 0 | 3.15M | 2.25M | 0 |
| Deferred income tax benefit | 11.20M | 12.01M | 9.93M | 20.10M | 30.21M | 0 | 3.15M | 2.25M | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -413.94K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -509K | 22K | -1.81M | 1.43M | -1.45M | 8.65M | 434K | 507K | 0 |
Cash generated by operating activities | -145.58M | -112.30M | -117.86M | -117.75M | -101.48M | -25.84M | -16.36M | -9.84M | -3.32M |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -10.98M | -10.84M | -8.85M | -14.68M | -18.66M | -8.77M | -2.87M | -1.85M | -762.06K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -10.98M | -10.84M | -8.85M | -14.68M | -18.66M | -7.64M | -2.87M | -1.85M | -754.14K |
Financing activities | |||||||||
Common Stock Issued | -883K | 163.85M | 245.9M | 74.41M | 115.92M | 128.70M | 127.68M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -883K | 223.61M | 284.06M | 74.41M | 108.86M | 117.48M | 127.68M | 32.22M | 12.22M |
Net Change In Cash | -142.42M | 72.08M | 156.59M | -57.34M | -6.12M | 86.97M | 109.01M | 17.85M | 8.14M |
Cash at end of period | 240.33M | 382.76M | 310.67M | 154.08M | 211.43M | 189.29M | 137.07M | 28.05M | 8.14M |
| Data source | Data source | Data source | Data source | Data source | Data source |